Inozyme Pharmainc Stock Price Prediction
INZY Stock | USD 4.44 0.11 2.54% |
Oversold Vs Overbought
35
Oversold | Overbought |
Inozyme PharmaInc stock price prediction is an act of determining the future value of Inozyme PharmaInc shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Inozyme PharmaInc's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Inozyme PharmaInc and does not consider all of the tangible or intangible factors available from Inozyme PharmaInc's fundamental data. We analyze noise-free headlines and recent hype associated with Inozyme PharmaInc, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Inozyme PharmaInc's stock price prediction:EPS Estimate Next Quarter (0.32) | EPS Estimate Current Year (1.50) | EPS Estimate Next Year (1.60) | Wall Street Target Price 20.33 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Inozyme PharmaInc based on different types of headlines from major news networks to social media. The Inozyme stock price prediction module provides an analysis of price elasticity to changes in media outlook on Inozyme PharmaInc over a specific investment horizon. Using Inozyme PharmaInc hype-based prediction, you can estimate the value of Inozyme PharmaInc from the perspective of Inozyme PharmaInc response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Inozyme PharmaInc using Inozyme PharmaInc's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Inozyme using crowd psychology based on the activity and movement of Inozyme PharmaInc's stock price.
Inozyme PharmaInc Implied Volatility | 143.6 |
Inozyme PharmaInc's implied volatility exposes the market's sentiment of Inozyme PharmaInc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Inozyme PharmaInc's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Inozyme PharmaInc stock will not fluctuate a lot when Inozyme PharmaInc's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Inozyme PharmaInc. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Inozyme PharmaInc to buy its stock at a price that has no basis in reality. In that case, they are not buying Inozyme because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Inozyme PharmaInc after-hype prediction price | USD 4.36 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Inozyme |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Inozyme PharmaInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Inozyme PharmaInc After-Hype Price Prediction Density Analysis
As far as predicting the price of Inozyme PharmaInc at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Inozyme PharmaInc or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Inozyme PharmaInc, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Inozyme PharmaInc Estimiated After-Hype Price Volatility
In the context of predicting Inozyme PharmaInc's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Inozyme PharmaInc's historical news coverage. Inozyme PharmaInc's after-hype downside and upside margins for the prediction period are 0.22 and 8.87, respectively. We have considered Inozyme PharmaInc's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Inozyme PharmaInc is slightly risky at this time. Analysis and calculation of next after-hype price of Inozyme PharmaInc is based on 3 months time horizon.
Inozyme PharmaInc Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Inozyme PharmaInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inozyme PharmaInc backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Inozyme PharmaInc, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.24 | 4.51 | 0.08 | 0.02 | 8 Events / Month | 7 Events / Month | In about 8 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.44 | 4.36 | 1.80 |
|
Inozyme PharmaInc Hype Timeline
Inozyme PharmaInc is currently traded for 4.44. The entity has historical hype elasticity of -0.08, and average elasticity to hype of competition of 0.02. Inozyme is forecasted to decline in value after the next headline, with the price expected to drop to 4.36. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.8%, whereas the daily expected return is currently at -0.24%. The volatility of related hype on Inozyme PharmaInc is about 6998.28%, with the expected price after the next announcement by competition of 4.46. About 93.0% of the company shares are owned by institutional investors. The book value of Inozyme PharmaInc was currently reported as 2.27. The company recorded a loss per share of 1.37. Inozyme PharmaInc had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Inozyme PharmaInc Basic Forecasting Models to cross-verify your projections.Inozyme PharmaInc Related Hype Analysis
Having access to credible news sources related to Inozyme PharmaInc's direct competition is more important than ever and may enhance your ability to predict Inozyme PharmaInc's future price movements. Getting to know how Inozyme PharmaInc's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Inozyme PharmaInc may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
DAWN | Day One Biopharmaceuticals | 0.63 | 9 per month | 4.41 | 0.03 | 6.30 | (8.71) | 24.09 | |
XFOR | X4 Pharmaceuticals | 0.16 | 9 per month | 4.97 | 0.13 | 10.47 | (9.09) | 40.83 | |
ABOS | Acumen Pharmaceuticals | 0.1 | 7 per month | 3.87 | (0.01) | 7.28 | (5.98) | 23.58 | |
MREO | Mereo BioPharma Group | 0.05 | 5 per month | 0.00 | (0.09) | 6.05 | (6.07) | 17.19 | |
TERN | Terns Pharmaceuticals | (0.27) | 7 per month | 5.24 | (0.02) | 8.64 | (8.38) | 27.76 | |
PDSB | PDS Biotechnology Corp | (0.03) | 9 per month | 0.00 | (0.10) | 7.51 | (9.16) | 26.33 | |
HOOK | Hookipa Pharma | (0.02) | 7 per month | 3.20 | 0.07 | 9.88 | (6.17) | 24.40 | |
ELDN | Eledon Pharmaceuticals | (0.08) | 5 per month | 4.20 | 0.05 | 6.93 | (6.53) | 35.55 | |
AMLX | Amylyx Pharmaceuticals | 0.04 | 7 per month | 0.00 | (0.16) | 6.96 | (8.30) | 103.39 |
Inozyme PharmaInc Additional Predictive Modules
Most predictive techniques to examine Inozyme price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Inozyme using various technical indicators. When you analyze Inozyme charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Inozyme PharmaInc Predictive Indicators
The successful prediction of Inozyme PharmaInc stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Inozyme PharmaInc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Inozyme PharmaInc based on analysis of Inozyme PharmaInc hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Inozyme PharmaInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Inozyme PharmaInc's related companies. Story Coverage note for Inozyme PharmaInc
The number of cover stories for Inozyme PharmaInc depends on current market conditions and Inozyme PharmaInc's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Inozyme PharmaInc is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Inozyme PharmaInc's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Inozyme PharmaInc Short Properties
Inozyme PharmaInc's future price predictability will typically decrease when Inozyme PharmaInc's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Inozyme PharmaInc often depends not only on the future outlook of the potential Inozyme PharmaInc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Inozyme PharmaInc's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 51.8 M | |
Cash And Short Term Investments | 188.6 M |
Check out Inozyme PharmaInc Basic Forecasting Models to cross-verify your projections. For more information on how to buy Inozyme Stock please use our How to Invest in Inozyme PharmaInc guide.Note that the Inozyme PharmaInc information on this page should be used as a complementary analysis to other Inozyme PharmaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Inozyme Stock analysis
When running Inozyme PharmaInc's price analysis, check to measure Inozyme PharmaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inozyme PharmaInc is operating at the current time. Most of Inozyme PharmaInc's value examination focuses on studying past and present price action to predict the probability of Inozyme PharmaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inozyme PharmaInc's price. Additionally, you may evaluate how the addition of Inozyme PharmaInc to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Commodity Directory Find actively traded commodities issued by global exchanges |
Is Inozyme PharmaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inozyme PharmaInc. If investors know Inozyme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inozyme PharmaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.37) | Return On Assets (0.28) | Return On Equity (0.55) |
The market value of Inozyme PharmaInc is measured differently than its book value, which is the value of Inozyme that is recorded on the company's balance sheet. Investors also form their own opinion of Inozyme PharmaInc's value that differs from its market value or its book value, called intrinsic value, which is Inozyme PharmaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inozyme PharmaInc's market value can be influenced by many factors that don't directly affect Inozyme PharmaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inozyme PharmaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inozyme PharmaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inozyme PharmaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.